Interferon-gamma - Hayashibara

Drug Profile

Interferon-gamma - Hayashibara

Alternative Names: Interferon-gamma-n1; Ogamma; Ogamma 100; OH 6000

Latest Information Update: 07 Jun 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Hayashibara
  • Developer Hayashibara; Otsuka Pharmaceutical
  • Class Antineoplastics; Antivirals; Interferons; Lymphokines
  • Mechanism of Action Interferon gamma stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Skin cancer

Most Recent Events

  • 26 Jun 2000 Hayashibara and Amarillo collaborate on inhalation formulation
  • 05 Aug 1997 Launched for Skin cancer in Japan (Parenteral)
  • 03 Oct 1996 Preregistration for Skin cancer in Japan (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top